Cargando…
Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446343/ https://www.ncbi.nlm.nih.gov/pubmed/32923848 http://dx.doi.org/10.1200/PO.19.00189 |
_version_ | 1783574141712990208 |
---|---|
author | Wirth, Lori J. Kohno, Takashi Udagawa, Hibiki Matsumoto, Shingo Ishii, Genichiro Ebata, Kevin Tuch, Brian B. Zhu, Edward Y. Nguyen, Michele Smith, Steve Hanson, Lauren M. Burkard, Michael R. Cable, LouAnn Blake, James F. Condroski, Kevin R. Brandhuber, Barbara J. Andrews, Steve Rothenberg, S. Michael Goto, Koichi |
author_facet | Wirth, Lori J. Kohno, Takashi Udagawa, Hibiki Matsumoto, Shingo Ishii, Genichiro Ebata, Kevin Tuch, Brian B. Zhu, Edward Y. Nguyen, Michele Smith, Steve Hanson, Lauren M. Burkard, Michael R. Cable, LouAnn Blake, James F. Condroski, Kevin R. Brandhuber, Barbara J. Andrews, Steve Rothenberg, S. Michael Goto, Koichi |
author_sort | Wirth, Lori J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7446343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-74463432020-09-11 Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer Wirth, Lori J. Kohno, Takashi Udagawa, Hibiki Matsumoto, Shingo Ishii, Genichiro Ebata, Kevin Tuch, Brian B. Zhu, Edward Y. Nguyen, Michele Smith, Steve Hanson, Lauren M. Burkard, Michael R. Cable, LouAnn Blake, James F. Condroski, Kevin R. Brandhuber, Barbara J. Andrews, Steve Rothenberg, S. Michael Goto, Koichi JCO Precis Oncol Case Report American Society of Clinical Oncology 2019-09-11 /pmc/articles/PMC7446343/ /pubmed/32923848 http://dx.doi.org/10.1200/PO.19.00189 Text en © 2019 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Case Report Wirth, Lori J. Kohno, Takashi Udagawa, Hibiki Matsumoto, Shingo Ishii, Genichiro Ebata, Kevin Tuch, Brian B. Zhu, Edward Y. Nguyen, Michele Smith, Steve Hanson, Lauren M. Burkard, Michael R. Cable, LouAnn Blake, James F. Condroski, Kevin R. Brandhuber, Barbara J. Andrews, Steve Rothenberg, S. Michael Goto, Koichi Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer |
title | Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer |
title_full | Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer |
title_fullStr | Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer |
title_full_unstemmed | Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer |
title_short | Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer |
title_sort | emergence and targeting of acquired and hereditary resistance to multikinase ret inhibition in patients with ret-altered cancer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446343/ https://www.ncbi.nlm.nih.gov/pubmed/32923848 http://dx.doi.org/10.1200/PO.19.00189 |
work_keys_str_mv | AT wirthlorij emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT kohnotakashi emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT udagawahibiki emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT matsumotoshingo emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT ishiigenichiro emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT ebatakevin emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT tuchbrianb emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT zhuedwardy emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT nguyenmichele emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT smithsteve emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT hansonlaurenm emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT burkardmichaelr emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT cablelouann emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT blakejamesf emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT condroskikevinr emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT brandhuberbarbaraj emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT andrewssteve emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT rothenbergsmichael emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer AT gotokoichi emergenceandtargetingofacquiredandhereditaryresistancetomultikinaseretinhibitioninpatientswithretalteredcancer |